ARE LABS / RESEARCH
Explore the questions we investigated, the measurements we made and what the results mean for product development.
8 studies found
Packaging & Stability
The work separated temperature-related changes in the formulation and applicator from reduced-pressure leakage risk across three anonymized package variants.
Selected findingAt 40 °C, maximum losses were 93 mg, 52 mg, and 51 mg; the 93 mg result came from one anomalous unit, while the maximum among the remaining Variant A units was 46 mg.
Inhalation & Drug Delivery
The study established an early performance baseline for comparing the two variants and provided data for a regulatory-facing Phase 1 characterization package. It did not assess clinical efficacy or support claims of approval.
Selected findingRecovered material was predominantly classified in the nasal or upper-airway region for both variants.
Air-Cleaner Performance
The method addressed a product-mechanism question that standard chamber decay testing does not isolate: what viable bioaerosol concentration remains one minute after a new challenge enters room air that has already been treated?
Selected findingThe method compared viable bioaerosol concentration after a one-minute post-aerosolization mixing period in matched control and pretreated-room conditions.
Air-Cleaner Performance
The study linked laboratory-style air cleaner evidence with repeated measurements in occupied schools, modeled infection probability, and attendance-related outcomes.
Selected findingIllness-related absenteeism was also lower during the same seven-week study period, though the article avoids treating attendance differences as proof of causation.
Aerosol Characterization
The study characterized differences among the tested fragrance aerosols in spray particle-size distribution and time-resolved chamber counts under defined conditions.
Selected findingGroup-average D[4,3] was 31.49 µm for Test Article A and 75.03-89.77 µm for Comparator groups B-D.
Air-Cleaner Performance
The work helped Glow Guardian move from an early concept to a public-facing product story supported by controlled bioaerosol data and a granted patent.
Selected findingThe final broad-range study showed measurable reductions across virus surrogates, bacteria, mold spores, and bacterial endospores.
Exposure Assessment
The work helped the client answer the relevant inhalation exposure question instead of relying on a broad bulk-material screen.
Selected findingThe method focused on the respirable aerosol fraction of the powder rather than total TiO2 in the compact.
Aerosol Characterization
The client needed a measured baseline for surface particle accumulation across operating spaces, with enough spatial detail to compare buildings, halls, and sampling heights.
Selected findingAcross 123 primary slides, mean and median mass deposition rates were 14.7 and 7.5 mg/m²/day.